3 Results for "

secondary progressive multiple sclerosis

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "secondary progressive multiple sclerosis" in MCE Product Catalog:

11
11 Cited Publications
Cat. No.: HY-12355A
CAS No.: 1234627-85-0
Purity:  99.64%
Synonyms: BAF-312 hemifumarate
Siponimod (BAF-312) hemifumarate is an orally active, blood-brain barrier penetrant dual agonist of S1P1/S1P5, with EC50 values of 0.39 nM and 0.98 nM, respectively. Siponimod hemifumarate induces S1P1 internalization, activates GIRK channels, inhibits lymphocyte egress, reduces peripheral lymphocyte counts, triggers transient bradycardia, prevents synaptic neurodegeneration, promotes remyelination, alleviates demyelination, and prevents the loss of GABAergic interneurons. Siponimod hemifumarate can be used in research related to multiple sclerosis .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-109192
CAS No.: 1971920-73-6
Purity:  99.79%
Synonyms: SAR442168; PRN2246
Target:  

Btk

Tolebrutinib (SAR442168) is an orally active, selective, and blood-brain barrier-penetrant BTK inhibitor with neuroactive properties. Tolebrutinib is being investigated for use in multiple sclerosis (MS), particularly secondary progressive multiple sclerosis (SPMS). .
loading...
    loading...
Cat. No.: HY-109192R
CAS No.: 1971920-73-6
Synonyms: SAR442168 (Standard); PRN2246 (Standard)
Tolebrutinib (SAR442168) (Standard) is the analytical standard of Tolebrutinib (HY-109192). This product is intended for research and analytical applications. Tolebrutinib (SAR442168) is an orally active, selective, and blood-brain barrier-penetrant BTK inhibitor with neuroactive properties. Tolebrutinib is being investigated for use in multiple sclerosis (MS), particularly secondary progressive multiple sclerosis (SPMS) .
loading...
    loading...